Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Geron Corporation
GERN · SEC Filings
website
258
Geron Corporation is an advanced-stage biopharmaceutical company dedicated to the creation and marke...
Price
0.9965
Market Cap
642.47 M
Float
558.08 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about GERN
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Geron Corporation
GERN · SEC Filings
558.08 M
Float
0.9965
Price
642.47 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 4, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 5, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 6, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 2, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 7, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 6, 2025
News
TYPE
HEADLINE
FILED AT
8-K
Geron Reports Third Quarter 2026 Financial Results and Business Highlights
Nov 4, 2026
8-K
Geron Corporation Discontinues Phase 3 IMpactMF Clinical Trial of Imetelstat in Relapsed/Refractory Myelofibrosis
Oct 28, 2026
8-K
Geron Corporation Reports Second Quarter 2026 Financial Results and Business Highlights
Aug 6, 2026
8-K
Geron Corporation Announces Results of 2026 Annual Meeting of Stockholders
May 27, 2026
8-K
Geron Corporation Appoints Patricia S. Andrews and Constantine Chinoporos to Board of Directors
Mar 26, 2026
8-K
Geron Corporation Reports Q4 and Full Year 2025 Financial Results and Provides 2026 Guidance
Feb 25, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B5
41,999,998 Shares of Common Stock
Mar 19, 2024
424B5
Common Stock
Nov 2, 2023
424B5
55,876,297 Shares of Common Stock
Jan 6, 2023
424B5
Shares of Common Stock
Jan 4, 2023
424B5
53,333,334 Shares of Common Stock
Mar 30, 2022
424B5
$350,000,000Common StockPreferred StockDebt SecuritiesWarrants
Mar 29, 2022
Registrations
TYPE
HEADLINE
FILED AT
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 5, 2026
S-3ASR
March 2026 SHELF + ATM
Mar 2, 2026
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 6, 2025
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 30, 2025
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 10, 2025
S-8
Registration
Aug 3, 2023
Proxies
TYPE
HEADLINE
FILED AT
Ownerships
TYPE
HEADLINE
FILED AT
4
Spiegel Robert J. (Reporting)
Oct 1, 2026
SCHEDULE 13G/A
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Aug 14, 2026
SCHEDULE 13G
STATE STREET CORP (Filed by)
Aug 7, 2026
4
Spiegel Robert J. (Reporting)
Jul 1, 2026
4
Spiegel Robert J. (Reporting)
May 26, 2026
4
O'Farrell Elizabeth G. (Reporting)
May 26, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Nov 9, 2020
CORRESP
Form CORRESP - Correspondence
Nov 4, 2020
CORRESP
Form CORRESP - Correspondence
Oct 9, 2020
CORRESP
Form CORRESP - Correspondence
Oct 7, 2020
LETTER
Form UPLOAD - SEC-generated letter
Sep 10, 2020
CT ORDER
Form CT ORDER - Confidential treatment order
May 3, 2019
